Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Arm 1 (for people with a breast lesion being assessed)
Who might be able to join this trial:
- People aged between 20 and 90 years old
- People who are female
- People whose breast lesion can be seen on a standard ultrasound scan during their diagnostic assessment
- People whose breast lesion has been given a suspicion rating of 4a, 4b, 4c, or 5 on the standardised breast imaging scale (this generally means the lesion has been identified as needing further investigation)
Who may not be able to join:
- People who are unable to give informed consent to participate
- People who are unable to communicate in English
- People who are unable to stay completely still for 15 minutes
- People who have breast implants
- People whose breast lesion is located more than 4 cm below the skin surface
- People who are pregnant or currently breastfeeding
- People who have a pacemaker or an implanted heart device that corrects irregular heartbeats
- People who have previously had a mastectomy (surgical removal of a breast)
- People who have previously had a biopsy or surgery at the site of the lesion being studied
- People who are male
Arm 2 (for people with a confirmed breast cancer diagnosis undergoing treatment)
Who might be able to join this trial:
- People aged between 20 and 90 years old
- People who are female
- People whose breast lesion can be seen on a standard ultrasound scan during their diagnostic assessment
- People whose breast lesion has been given a rating of 6 on the standardised breast imaging scale (meaning cancer has already been confirmed) and who are scheduled to receive chemotherapy before surgery for a stage 2 or 3 breast cancer
Who may not be able to join:
- People who are unable to give informed consent to participate
- People who are unable to communicate in English
- People who are unable to stay completely still for 15 minutes
- People who have breast implants
- People whose breast lesion is located more than 4 cm below the skin surface
- People who are pregnant or currently breastfeeding
- People who have a pacemaker or an implanted heart device that corrects irregular heartbeats
- People who have previously had a mastectomy (surgical removal of a breast)
- People who have previously had a biopsy or surgery at the site of the lesion being studied
- People who are male
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Caterina Gallippi, PhD, Lampe Joint Department of Biomedical Engineering
Phone: 919-843-9463
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ARFI Peak Displacement (PD) in lesion (Study Arm 1); ARFI Peak Displacement (PD) in surrounding tissue (Study Arm 1); VisR Relative Elasticity (RE) in lesion (Study Arm 1); VisR Relative Elasticity (RE) in surrounding tissue (Study Arm 1); VisR Relative Viscosity (RV) in lesion (Study Arm 1); VisR Relative Viscosity (RV) in surrounding tissue (Study Arm 1); ARFI PD DoA in lesion (Study Arm 1); ARFI PD DoA in surrounding tissue (Study Arm 1); VisR RE DoA in lesion (Study Arm 1); VisR RE DoA in surrounding tissue (Study Arm 1); VisR RV DoA in lesion (Study Arm 1); VisR RV DoA in surrounding tiss...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.